Jane Street’s AYTU BioPharma AYTU Stock Holding History

Jane Street’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,594	Closed	-$17.4K	–	9001
2022 Q4	$17.4K	Buy	4,594 +3,917	+579%	+$14.7K	﹤0.01%	8638
2022 Q3	$3K	Buy	+677	New	+$5.14K	﹤0.01%	9489
2021 Q3	–	Sell	-786	Closed	-$78K	–	9906
2021 Q2	$78K	Buy	+786	New	+$92.2K	﹤0.01%	9366
2020 Q4	–	Sell	-285	Closed	-$68K	–	7449
2020 Q3	$68K	Sell	285 -1,171	-80%	-$301K	﹤0.01%	6846
2020 Q2	$414K	Buy	+1,456	New	+$441K	﹤0.01%	5360

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's AYTU Position: Q1 2023 in Review

Jane Street sold out of AYTU BioPharma (AYTU) in Q1 2023, closing a stake of 4,594 shares — an estimated $17.4K sold.

Jane Street first reported a position in AYTU in Q2 2020 and held it in 5 quarters. The position peaked at $414K in Q2 2020. 21 funds tracked by Wall St. Rank hold AYTU as of Q1 2023.

Jane Street reported no remaining AYTU BioPharma position as of Q1 2023 after selling out during the quarter.
Jane Street sold 4,594 AYTU BioPharma shares in Q1 2023, an estimated $17.4K.
Jane Street first reported a position in AYTU BioPharma in Q2 2020 and held it in 5 quarters.
Jane Street's AYTU BioPharma position peaked at $414K in Q2 2020.
21 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.